Long-Term Use of Besremi in Polycythemia Vera: 5... - MPN Voice

MPN Voice

10,403 members14,353 posts

Long-Term Use of Besremi in Polycythemia Vera: 5-Year Results from a Randomized Controlled Study and Its Extension

Manouche profile image
14 Replies

« Patients with polycythemia vera (PV) require life-long treatment to prevent thromboembolic events and minimize the risk of progression. Ropeginterferon alpha-2b (BESREMi®; hereafter ropeg) may ultimately modify the natural history of PV by selectively targeting the malignant clone. In the PROUD-PV/CONTINUATION-PV studies, long-term treatment with ropeg was compared with standard cytoreductive therapy regarding thromboembolic and other adverse events as well as evolution of hematologic and molecular parameters over five years. »

ash.confex.com/ash/2020/web...

Written by
Manouche profile image
Manouche
To view profiles and participate in discussions please or .
14 Replies
Aldebaran25 profile image
Aldebaran25

Thank you. Very encouraging 😊

MPort profile image
MPort

Thanks for posting. This is encouraging. I wonder if those of us on Pegasys will be able to switch over?

Manouche profile image
Manouche in reply to MPort

They will, although some haems will be reluctant to do so if their patients are doing well under Pegasys.

hunter5582 profile image
hunter5582

More promising data for the use of Besremi. Besremi was mentioned in the recent MPN Advocacy Intl. Webinar with hope that it will be much easier for PV patients to access the drug once it is FDA approved for PV. Hopefully it will be so.

ggrana profile image
ggrana

Anyone know when it’s coming to the USA?

BeHealthy1986 profile image
BeHealthy1986 in reply to ggrana

Hi Grace, I asked Dr Mauro this question last time. He said it is not approved yet. He also mentioned the ingredient is same as Pegasys but works longer with less side effects.

ggrana profile image
ggrana in reply to BeHealthy1986

I definitely want to try it I hope he agrees. I am pushing for it it sounds promising

Aneliv9 profile image
Aneliv9

Is there any country that Besremi is already approved???

Dovme profile image
Dovme in reply to Aneliv9

Germany approved it and it has been in use since late 2019. I believe it has been approved by the EU as a whole and also some Asian countries

Aneliv9 profile image
Aneliv9 in reply to Dovme

So here in Greece ( Europe) do we have Besremi approved for PV?

Dovme profile image
Dovme in reply to Aneliv9

Hi l think so as it was approved by the EU body for all 28 states plus Norway Iceland

aoporphan.com/po_en/our-com...

saturn0325 profile image
saturn0325 in reply to Aneliv9

Taiwan has approved it.

MPNBlog profile image
MPNBlog

Many thanks for posting this link Manouche.

Maisie10 profile image
Maisie10

Thank you for sharing

You may also like...

BESREMI ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES

0001). Event-free survival (risk events: disease progression, death and thromboembolic events) over...

ASH 2019 | Ropeg in polycythemia vera: long-term PROUD-PV and CONTI-PV results

https://www.vjhemonc.com/video/elvsbiyxlco-ropeg-in-polycythemia-vera-long-term-proud-pv-and-conti-p

Increased Besremi Dose to Be Studied for Polycythemia Vera Treatment

regimens of Besremi. The trial will involve approximately 100 patients with polycythemia vera....

The Gut Microbiota in Patients with Polycythemia Vera is Distinct from that of Healthy Controls and Varies by Treatment

interferon-α2 (IFN) treatment of patients with PV has been shown to be disease-modifying in terms...

AOP Orphan announces 5-year results on BESREMi® in PV at the ASH Annual Meeting 2020

nounces-5-year-results-on-besremi-ropeginterferon-alfa-2b-in-pv-at-the-ash-annual-meeting-2020/